Author: Joshua Schwartz

Massage Envy Franchises Accused of Widespread Sexual Assault

gavel

More than 180 women claim they were sexually assaulted while receiving treatments at Massage Envy, a national chain of day-spas. Massage Envy has grown into a multibillion-dollar business that operates more than 1,170 franchise locations in 49 states. The claims were uncovered by a BuzzFeed News investigation, which gathered information from law...

Is It Dangerous to Do Your Own Breast Exam?

There was recently an article featured in Refinery29, a digital media outlet that focusses on women’s issues, that raised the questions as to whether you should do your own breast exam. As the Refinery29 piece points out, medical professionals have been recommending that patients perform their own breast examinations for decades. However, now it ...

Is Uber Doing Enough to Protect Passengers from Sexual Assault?

wrongful 04

Uber has shot to popularity over the past few years as an alternative to driving, using public transportation or taking a cab. However, a recent Penn Live report may bring the rideshare company’s rise to a sudden stop. According to the story, Uber may have a problem with drivers sexually assaulting passengers. In November, an Uber sexual ass...

Future Leaders – Get Involved Today for Our Tomorrow

Attorney Josh Schwartz is the Chair of the Philadelphia Trial Lawyers Association Future leaders Section and is excited about the growing involvement of the younger members of the trial bar. The Future Leader Section of the Philadelphia Trial Lawyers Association includes members who have been practicing for ten years or less, but their involvement ...

Major Drug Manufacturer Voluntarily Recalls Generic Drugs

Actavis Totowa, a major generic drug manufacturer, is voluntarily recalling all products manufactured at its Little Falls, New Jersey plant. The recall comes after a FDA inspection that found the manufacturing standards were not up to FDA or Actavis standards. The following are the prescribed medications affected by the recall: Amantadine 1...